Human Genetics Market Outlook:
Human Genetics Market size was over USD 32.83 billion in 2025 and is poised to exceed USD 92.38 billion by 2035, growing at over 10.9% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of human genetics is evaluated at USD 36.05 billion.
Human genetics adoption is gaining traction due to advancements in gene sequencing technologies and an increasing need for personalized health solutions. Genetic testing permits early diagnosis, evaluation of risk, and treatment approaches for various life-threatening diseases, including some rare diseases and cancers. In July 2023, Novartis Espana partnered with DBGen Ocular Genomics to deliver genetic testing services for retinitis pigmentosa and Leber congenital amaurosis. Such collaborations highlight the demand for precision diagnostics in human genetics market. The engagement in such partnerships underlines the commitment of industry players to continuous innovation. This also opens up prospects for further growth, as governments and private investors are continually investing in genetic research and infrastructure.
Government support for genetic testing and personalized medicine creates more scope for players in the human genetics market. Many governments fund national genomic initiatives to study population-specific genetic information, which could help achieve better results in public health and ensure innovative healthcare. As governments continue to emphasize funding in healthcare research and develop policies that favor genetic advancements, the growth in the global human genetics industry is expected to be sustained.
